(Q37728153)

22 August 2017

Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis (English)

1 reference

22 August 2017

1 reference

1 reference

Ying Ma

1

1 reference

22 August 2017

Bi-rong Lin

2

1 reference

22 August 2017

Bei Lin

3

1 reference

22 August 2017

Sheng Hou

4

1 reference

22 August 2017

Wei-zhu Qian

5

1 reference

22 August 2017

Jing Li

6

1 reference

22 August 2017

Min Tan

7

1 reference

22 August 2017

Jian Ma

8

1 reference

22 August 2017

Bo-hua Li

9

1 reference

22 August 2017

Hao Wang

10

1 reference

22 August 2017

Ai-dong Wen

11

1 reference

22 August 2017

Ya-jun Guo

12

1 reference

22 August 2017

1 March 2009

1 reference

Acta Pharmacologica Sinica

22 August 2017

1 reference

22 August 2017

30

1 reference

22 August 2017

3

1 reference

22 August 2017

364-371

1 reference

Abatacept in the treatment of rheumatoid arthritis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

Cytokine pathways and joint inflammation in rheumatoid arthritis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

CTLA-4 Overexpression Inhibits T Cell Responses through a CD28-B7-Dependent Mechanism

23 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

1 October 2018

https://api.crossref.org/works/10.1038%2FAPS.2009.13

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4002403

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19262560

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19262560

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Re: An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies, by Vaidya et al

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FAPS.2009.13

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/APS.2009.13

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference

22 August 2017

PubMed publication ID

19262560

1 reference